Chemistry and Hypoglycemic Activity of GPR119 Agonist ZB-16
This article is to highlight the chemical properties and primary pharmacology of novel GPR119 agonist ZB-16 and its analogs, which were rejected during the screening. Experiments were performed in vitro (specific activity, metabolism and cell toxicity) and in vivo (hypoglycemic activity and pharmaco...
Main Authors: | Ivan N. Tyurenkov, Denis V. Kurkin, Dmitry A. Bakulin, Elena V. Volotova, Evgeny I. Morkovin, Mikhail A. Chafeev, Ruben N. Karapetian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00543/full |
Similar Items
-
Influence of novel GPR119 agonist in combination with metformin and sitagliptin on glycemia, body weight and food intake in rats fed a high-fat diet
by: Ivan N. Tyurenkov, et al.
Published: (2019-12-01) -
GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy
by: Ji Hye Im, et al.
Published: (2018-11-01) -
Structure of human GPR119-Gs complex binding APD597 and characterization of GPR119 binding agonists
by: Ruixue Li, et al.
Published: (2024-01-01) -
Microbial biotransformation to obtain stilbene methylglucoside with GPR119 agonistic activity
by: Yu Peng, et al.
Published: (2023-03-01) -
Optimisation of novel 4, 8-disubstituted dihydropyrimido[5,4-b][1,4]oxazine derivatives as potent GPR 119 agonists
by: Yuanying Fang, et al.
Published: (2020-01-01)